G C A T T A C G G C A T genes Article Transcriptomic Profiling Identifies Differentially Expressed Genes in Palbociclib-Resistant ER+ MCF7 Breast Cancer Cells Lilibeth Lanceta 1, Conor O’Neill 2, Nadiia Lypova 1 , Xiahong Li 3, Eric Rouchka 4, Sabine Waigel 1, Jorge G. Gomez-Gutierrez 5,6 , Jason Chesney 1,6 and Yoannis Imbert-Fernandez 1,6,* 1 Department of Medicine, School of Medicine, University of Louisville, Louisville, KY 40202, USA;
[email protected] (L.L.);
[email protected] (N.L.);
[email protected] (S.W.);
[email protected] (J.C.) 2 College of Medicine, University of Kentucky, Lexington, KY 40506, USA;
[email protected] 3 Department of Anatomical Sciences and Neurobiology, Bioinformatics Core, University of Louisville, Louisville, KY 40202, USA;
[email protected] 4 Department of Computer Engineering and Computer Science, University of Louisville, Louisville, KY 40292, USA;
[email protected] 5 Department of Surgery, School of Medicine, University of Louisville, Louisville, KY 40202, USA;
[email protected] 6 James Graham Brown Cancer Center School of Medicine, University of Louisville, Louisville, KY 40202, USA * Correspondence:
[email protected]; Tel.: +1-502-852-6570 Received: 20 March 2020; Accepted: 18 April 2020; Published: 24 April 2020 Abstract: Acquired resistance to cyclin-dependent kinases 4 and 6 (CDK4/6) inhibition in estrogen receptor-positive (ER+) breast cancer remains a significant clinical challenge. Efforts to uncover the mechanisms underlying resistance are needed to establish clinically actionable targets effective against resistant tumors. In this study, we sought to identify differentially expressed genes (DEGs) associated with acquired resistance to palbociclib in ER+ breast cancer.